THE RX TO OTC COMPANY Trademark

Trademark Overview

On Wednesday, August 1, 2018, a trademark application was filed for THE RX TO OTC COMPANY with the United States Patent and Trademark Office. The USPTO has given the THE RX TO OTC COMPANY trademark a serial number of 88061544. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, February 6, 2020. This trademark is owned by Prequient Inc.. The THE RX TO OTC COMPANY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research services
the rx to otc company

General Information

Serial Number88061544
Word MarkTHE RX TO OTC COMPANY
Filing DateWednesday, August 1, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, February 6, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical research services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 7, 2018
Primary Code042
First Use Anywhere DateMonday, January 8, 2018
First Use In Commerce DateMonday, January 8, 2018

Trademark Owner History

Party NamePrequient Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoonton, NJ 07005

Trademark Events

Event DateEvent Description
Thursday, February 6, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, February 6, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, July 26, 2019NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, July 26, 2019EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, July 26, 2019COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Friday, July 26, 2019EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Thursday, May 30, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 30, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 25, 2019ASSIGNED TO LIE
Tuesday, May 21, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 9, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 9, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 9, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 8, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 8, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 9, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 6, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 6, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 27, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 27, 2018NON-FINAL ACTION E-MAILED
Tuesday, November 27, 2018NON-FINAL ACTION WRITTEN
Monday, November 19, 2018ASSIGNED TO EXAMINER
Tuesday, August 7, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 4, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

company services research pharmaceutical